Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry

NCT: NCT04907240 · ACTIVE_NOT_RECRUITING

NCT IDNCT04907240
StatusACTIVE_NOT_RECRUITING
Start Date2021-10-09
Completion2035-10
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

Collect real-world post-market clinical follow-up data on patients treated with the GORE® VIABAHN® Endoprosthesis with PROPATEN Bioactive Surface (VSX)

Frequently Asked Questions

What is Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry?

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry is a clinical trial registered under NCT04907240. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04907240?

The current status of NCT04907240 (Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry) is: ACTIVE_NOT_RECRUITING.

When did Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry start?

Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry started on 2021-10-09.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.